Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
78
datasets available to search
ShareScore release 0.9.0
Dataset results
78 results for “HCC recurrence”
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
ClinicalTrials.gov study NCT04415567. IPD Sharing: YES. Countries: 1. Publications: 4.
Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation
ClinicalTrials.gov study NCT05910970. IPD Sharing: YES. Countries: 1. Publications: 5.
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00397540. IPD Sharing: Not stated. Countries: 1. Publications: 2.
New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin
<p><span><b>Background</b>: Several studies have resulted in controversial data about the recurrence or new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were treated with direct-acting antivirals (DAAs). </span></p> <p><span><b>Aim:</b> This observational study aimed to assess the occurrence rate of HCC in patients who developed a sustained virological response (SVR).. </span></p> <p><span><b>Methods</b>: A six-month prospective study was done at the National Hepatology and Tropical Medicine Research Institute [NHTMRI] in Cairo, Egypt on 150 chronic hepatitis C (CHC) patients treated with sofosbuvir and daclatasvir with or without ribavirin. Patients were assigned into two groups according to their laboratory values to either receive sofosbuvir/daclatasvir and ribavirin (S/D/R) or receive only sofosbuvir/daclatasvir (S/D). The main outcome measure was the occurrence of HCC.</span></p> <p><span><b>Results</b>: SVR-12 was 100%. 8.5% of patients developed HCC in the S/D/R group, while 0% in the S/D group.</span></p> <p><span><b>Conclusion:</b> New incidence or recurrence of HCC may occur in CHC genotype 4 cirrhotic patients receiving sofosbuvir/daclatasvir and ribavirin (difficult to treat) although achieving SVR. The cause of HCC development in this study is cirrhosis, not the administered DAAs.</span></p>
A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation
ClinicalTrials.gov study NCT02719782. IPD Sharing: NO. Countries: 1. Publications: 4.
RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC
ClinicalTrials.gov study NCT02426450. IPD Sharing: Not stated. Countries: 1. Publications: 3.
HOPE Against Cancer Recurrence in HCC
ClinicalTrials.gov study NCT06717919. IPD Sharing: NO. Countries: 17. Publications: 1.
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
ClinicalTrials.gov study NCT06537193. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation
ClinicalTrials.gov study NCT02399735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HOPE to Reduce Tumour Recurrence After LT In Patients With HCC
ClinicalTrials.gov study NCT05876052. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection
ClinicalTrials.gov study NCT02654028. IPD Sharing: Not stated. Countries: 1. Publications: 3.
RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC
ClinicalTrials.gov study NCT02678013. IPD Sharing: YES. Countries: 1. Publications: 3.
Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC
ClinicalTrials.gov study NCT03806218. IPD Sharing: NO. Countries: 1. Publications: 1.
Adjuvant TACE to Reduce the HCC Recurrence After Resection
ClinicalTrials.gov study NCT02788526. IPD Sharing: NO. Countries: 1. Publications: 4.
RFA Versus SBRT for Recurrent Small HCC
ClinicalTrials.gov study NCT04047173. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC
ClinicalTrials.gov study NCT04663035. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes
ClinicalTrials.gov study NCT07192172. IPD Sharing: YES. Countries: 1. Publications: 1.
New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin
Open the record for dataset details and reuse information.
Laparoscopic Surgery VS RFA for Recurrent HCC
ClinicalTrials.gov study NCT02785380. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC
ClinicalTrials.gov study NCT02535117. IPD Sharing: Not stated. Countries: 0. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.